|
1.
|
Arrizabalaga M, Navarro J, Mora M, Castro
M, Extramiana J, Manas A, Diez J and Paniagua P: [Transitional
carcinomas of the urinary tract: synchronous and metachronous
lesions]. Actas Urol Esp. 18:782–796. 1994.
|
|
2.
|
Shen CH, Wang YH, Wang WC, Jou YC, Hsu HS,
Hsieh HY and Chiou HY: Inducible nitric oxide synthase promoter
polymorphism, cigarette smoking, and urothelial carcinoma risk.
Urology. 69:1001–1006. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Herr HW: Natural history of superficial
bladder tumors: 10- to 20-year follow-up of treated patients. World
J Urol. 15:84–88. 1997.PubMed/NCBI
|
|
4.
|
Pashos CL, Botteman MF, Laskin BL and
Redaelli A: Bladder cancer: epidemiology, diagnosis, and
management. Cancer Pract. 10:311–322. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Morey SS: American Urological Association
issues guidelines on the management of bladder cancer. Am Fam
Physician. 61:3734–3736. 2000.PubMed/NCBI
|
|
6.
|
Aguilera O, Fraga MF, Ballestar E, Paz MF,
Herranz M, Espada J, Garcia JM, Munoz A, Esteller M and
Gonzalez-Sancho JM: Epigenetic inactivation of the Wnt antagonist
DICKKOPF-1 (DKK-1) gene in human colorectal cancer. Oncogene.
25:4116–4121. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Forget MA, Turcotte S, Beauseigle D,
Godin-Ethier J, Pelletier S, Martin J, Tanguay S and Lapointe R:
The Wnt pathway regulator DKK1 is preferentially expressed in
hormone-resistant breast tumours and in some common cancer types.
Br J Cancer. 96:646–653. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Jiang T, Wang S, Huang L and Zhang S:
Clinical significance of serum DKK-1 in patients with gynecological
cancer. Int J Gynecol Cancer. 19:1177–1181. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Patil MA, Chua MS, Pan KH, Lin R, Lih CJ,
Cheung ST, Ho C, Li R, Fan ST, Cohen SN, Chen X and So S: An
integrated data analysis approach to characterize genes highly
expressed in hepatocellular carcinoma. Oncogene. 24:3737–3747.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Yamabuki T, Takano A, Hayama S, Ishikawa
N, Kato T, Miyamoto M, Ito T, Ito H, Miyagi Y, Nakayama H, Fujita
M, Hosokawa M, Tsuchiya E, Kohno N, Kondo S, Nakamura Y and Daigo
Y: Dikkopf-1 as a novel serologic and prognostic biomarker for lung
and esophageal carcinomas. Cancer Res. 67:2517–2525. 2007.
View Article : Google Scholar
|
|
11.
|
Niida A, Hiroko T, Kasai M, Furukawa Y,
Nakamura Y, Suzuki Y, Sugano S and Akiyama T: DKK1, a negative
regulator of Wnt signaling, is a target of the beta-catenin/TCF
pathway. Oncogene. 23:8520–8526. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Gonzalez-Sancho JM, Aguilera O, Garcia JM,
Pendas-Franco N, Pena C, Cal S, Garcia de Herreros A, Bonilla F and
Munoz A: The Wnt antagonist DICKKOPF-1 gene is a downstream target
of beta-catenin/TCF and is downregulated in human colon cancer.
Oncogene. 24:1098–1103. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Dulaimi E, Uzzo RG, Greenberg RE,
Al-Saleem T and Cairns P: Detection of bladder cancer in urine by a
tumor suppressor gene hypermethylation panel. Clin Cancer Res.
10:1887–1893. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Kastritis E, Murray S, Kyriakou F, Horti
M, Tamvakis N, Kavantzas N, Patsouris ES, Noni A, Legaki S,
Dimopoulos MA and Bamias A: Somatic mutations of adenomatous
polyposis coli gene and nuclear b-catenin accumulation have
prognostic significance in invasive urothelial carcinomas: evidence
for Wnt pathway implication. Int J Cancer. 124:103–108. 2009.
View Article : Google Scholar
|
|
15.
|
Marsit CJ, Karagas MR, Andrew A, Liu M,
Danaee H, Schned AR, Nelson HH and Kelsey KT: Epigenetic
inactivation of SFRP genes and TP53 alteration act jointly as
markers of invasive bladder cancer. Cancer Res. 65:7081–7085. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Maruyama R, Toyooka S, Toyooka KO, Harada
K, Virmani AK, Zochbauer-Muller S, Farinas AJ, Vakar-Lopez F, Minna
JD, Sagalowsky A, Czerniak B and Gazdar AF: Aberrant promoter
methylation profile of bladder cancer and its relationship to
clinicopathological features. Cancer Res. 61:8659–8663.
2001.PubMed/NCBI
|
|
17.
|
Stoehr R, Wissmann C, Suzuki H, Knuechel
R, Krieg RC, Klopocki E, Dahl E, Wild P, Blaszyk H, Sauter G, Simon
R, Schmitt R, Zaak D, Hofstaedter F, Rosenthal A, Baylin SB,
Pilarsky C and Hartmann A: Deletions of chromosome 8p and loss of
sFRP1 expression are progression markers of papillary bladder
cancer. Lab Invest. 84:465–478. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Urakami S, Shiina H, Enokida H, Kawakami
T, Kawamoto K, Hirata H, Tanaka Y, Kikuno N, Nakagawa M, Igawa M
and Dahiya R: Combination analysis of hypermethylated
Wnt-antagonist family genes as a novel epigenetic biomarker panel
for bladder cancer detection. Clin Cancer Res. 12:2109–2116. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Urakami S, Shiina H, Enokida H, Kawakami
T, Tokizane T, Ogishima T, Tanaka Y, Li LC, Ribeiro-Filho LA,
Terashima M, Kikuno N, Adachi H, Yoneda T, Kishi H, Shigeno K,
Konety BR, Igawa M and Dahiya R: Epigenetic inactivation of Wnt
inhibitory factor-1 plays an important role in bladder cancer
through aberrant canonical Wnt/beta-catenin signaling pathway. Clin
Cancer Res. 12:383–391. 2006. View Article : Google Scholar
|
|
20.
|
Kakiuchi S, Daigo Y, Ishikawa N, Furukawa
C, Tsunoda T, Yano S, Nakagawa K, Tsuruo T, Kohno N, Fukuoka M,
Sone S and Nakamura Y: Prediction of sensitivity of advanced
non-small cell lung cancers to gefitinib (Iressa, ZD1839). Hum Mol
Genet. 13:3029–3043. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Kakiuchi S, Daigo Y, Tsunoda T, Yano S,
Sone S and Nakamura Y: Genome-wide analysis of organ-preferential
metastasis of human small cell lung cancer in mice. Mol Cancer Res.
1:485–499. 2003.PubMed/NCBI
|
|
22.
|
Kikuchi T, Daigo Y, Ishikawa N, Katagiri
T, Tsunoda T, Yoshida S and Nakamura Y: Expression profiles of
metastatic brain tumor from lung adenocarcinomas on cDNA
microarray. Int J Oncol. 28:799–805. 2006.PubMed/NCBI
|
|
23.
|
Kikuchi T, Daigo Y, Katagiri T, Tsunoda T,
Okada K, Kakiuchi S, Zembutsu H, Furukawa Y, Kawamura M, Kobayashi
K, Imai K and Nakamura Y: Expression profiles of non-small cell
lung cancers on cDNA microarrays: identification of genes for
prediction of lymph-node metastasis and sensitivity to anti-cancer
drugs. Oncogene. 22:2192–2205. 2003. View Article : Google Scholar
|
|
24.
|
Taniwaki M, Daigo Y, Ishikawa N, Takano A,
Tsunoda T, Yasui W, Inai K, Kohno N and Nakamura Y: Gene expression
profiles of small-cell lung cancers: molecular signatures of lung
cancer. Int J Oncol. 29:567–575. 2006.PubMed/NCBI
|
|
25.
|
Yamabuki T, Daigo Y, Kato T, Hayama S,
Tsunoda T, Miyamoto M, Ito T, Fujita M, Hosokawa M, Kondo S and
Nakamura Y: Genome-wide gene expression profile analysis of
esophageal squamous cell carcinomas. Int J Oncol. 28:1375–1384.
2006.PubMed/NCBI
|
|
26.
|
Moon RT, Kohn AD, De Ferrari GV and Kaykas
A: WNT and beta-catenin signalling: diseases and therapies. Nat Rev
Genet. 5:691–701. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Reya T and Clevers H: Wnt signalling in
stem cells and cancer. Nature. 434:843–850. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Aman A and Piotrowski T: Wnt/beta-catenin
and Fgf signaling control collective cell migration by restricting
chemokine receptor expression. Dev Cell. 15:749–761. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Chamorro MN, Schwartz DR, Vonica A,
Brivanlou AH, Cho KR and Varmus HE: FGF-20 and DKK1 are
transcriptional targets of beta-catenin and FGF-20 is implicated in
cancer and development. EMBO J. 24:73–84. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Politou MC, Heath DJ, Rahemtulla A, Szydlo
R, Anagnostopoulos A, Dimopoulos MA, Croucher PI and Terpos E:
Serum concentrations of Dickkopf-1 protein are increased in
patients with multiple myeloma and reduced after autologous stem
cell transplantation. Int J Cancer. 119:1728–1731. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Yu B, Yang X, Xu Y, Yao G, Shu H, Lin B,
Hood L, Wang H, Yang S, Gu J, Fan J and Qin W: Elevated expression
of DKK1 is associated with cytoplasmic/nuclear beta-catenin
accumulation and poor prognosis in hepatocellular carcinomas. J
Hepatol. 50:948–957. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Stein JP, Lieskovsky G, Cote R, Groshen S,
Feng AC, Boyd S, Skinner E, Bochner B, Thangathurai D, Mikhail M,
Raghavan D and Skinner DG: Radical cystectomy in the treatment of
invasive bladder cancer: long-term results in 1,054 patients. J
Clin Oncol. 19:666–675. 2001.PubMed/NCBI
|
